Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 4/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29254239 | 0.82 | ACHE (0.38) | CA1CA2ALDH1A1MAPTTHRB | |
| SCHEMBL30426106 | 0.81 | ALDH1A1 (0.41) | CA1CA2ALDH1A1MAPTTHRB | |
| Diethanolamine SCHEMBL28937380 | 0.81 | NAAA (0.41) | ALDH1A1MAPTTHRBCNR1GAA | |
| SCHEMBL4924545 | 0.77 | ALDH1A1 (0.50) | ALDH1A1MAPTTHRBCNR1MAOA | |
| SCHEMBL16005449 | 0.77 | ALDH1A1 (0.50) | ALDH1A1MAPTTHRBCNR1MAOA | |
| SCHEMBL1045280 | 0.76 | LTA4H (0.33) | CA1CA2LTA4H | |
| SCHEMBL1632531 | 0.75 | GAA (0.52) | ALDH1A1MAPTLTA4HGAAHPGD | |
| SCHEMBL11232987 | 0.74 | ALDH1A1 (0.41) | CA1CA2ALDH1A1MAPTTHRB | |
| SCHEMBL6243312 | 0.74 | NAAA (0.56) | — | |
| Water SCHEMBL5636608 | 0.73 | GAA (0.50) | ALDH1A1MAPTLTA4HGAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10758490-B2 | Nanocapsules containing microemulsions | LIPOTEC, S.A. (ES) | 2020-09-01 | — | — | US | disclosed |
| EP-2618926-B1 | NANOCAPSULES CONTAINING MICROEMULSIONS | LIPOTEC SA (ES) | 2019-05-08 | — | — | EP | disclosed |
| EP-2536815-B1 | USE OF LIPOSOMES FOR THE TREATMENT OF TEXTILE MATERIALS | LIPOTEC SA (ES) | 2018-07-11 | — | — | EP | disclosed |
| EP-3272398-A1 | LIPID NANOPARTICLE CAPSULES | Lipotec S.A. (ES) | 2018-01-24 | — | — | EP | disclosed |
| US-9717659-B2 | Liposomes for the treatment of textile materials | LIPOTEC, S.A. (ES) | 2017-08-01 | — | — | US | disclosed |
| EP-2898774-A1 | Composition for the treatment of textile materials | Archroma IP GmbH (CH) | 2015-07-29 | — | — | EP | disclosed |
| US-20130216596-A1 | NANOCAPSULES CONTAINING MICROEMULSIONS | LIPOTEC, S.A. (ES) | 2013-08-22 | — | — | US | disclosed |
| EP-2618926-A2 | NANOCAPSULES CONTAINING MICROEMULSIONS | Lipotec, S.A. (ES) | 2013-07-31 | — | — | EP | disclosed |
| US-20130183358-A1 | LIPOSOMES FOR THE TREATMENT OF TEXTILE MATERIALS | LIPOTEC, S.A. (ES) | 2013-07-18 | — | — | US | disclosed |
| EP-2549977-A2 | LIPID NANOPARTICLE CAPSULES | Lipotec, S.A. (ES) | 2013-01-30 | — | — | EP | disclosed |
| US-20130017239-A1 | LIPID NANOPARTICLE CAPSULES | LIPOTEC S.A. (ES) | 2013-01-17 | — | — | US | disclosed |
| WO-2012038061-A2 | NANOCAPSULES CONTAINING MICROEMULSIONS | LIPOTEC, S.A. (ES) | 2012-03-29 | — | — | WO | disclosed |
| WO-2011116963-A2 | LIPID NANOPARTICLE CAPSULES | LIPOTEC S.A. (ES) | 2011-09-29 | — | — | WO | disclosed |
| US-20090018200-A1 | COMPOSITION CONTAINING A PHENANTHRENOL | L'OREAL (FR) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018200-A1 | COMPOSITION CONTAINING A PHENANTHRENOL | CUTA, AHR, TYR | CA1 4884/4885CA2 4868/4885ALDH1A1 4116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.